Squarepoint Ops »

Inhibikase Therapeutics shares owned by Squarepoint Ops

Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Squarepoint Ops from 13F filings

Historical chart of Squarepoint Ops investment in Inhibikase Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Inhibikase Therapeutics held by Squarepoint Ops consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibikase Therapeutics by Squarepoint Ops

Quarter filed Position value Share count Share price at filing
2026-03-31 $52k 31k 1.68
2024-12-31 $92k 28k 3.25

More positions owned by Squarepoint Ops

Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Tesla Motors (TSLA)
Apple (AAPL)
Amazon (AMZN)
Micron Technology (MU)
Ishares Tr Msci Emg Mkt Etf (EEM)
Broadcom (AVGO)
Vaneck Etf Trust Semiconductr Etf (SMH)
Oracle Corporation (ORCL)

View all positions for Squarepoint Ops

Top funds holding Inhibikase Therapeutics

Sands Capital Ventures
Soleus Capital Management
Fairmount Funds Management
Trails Edge Capital Partners
ADAR1 Capital Management
BlackRock
Blackstone Group
Siren
Commodore Capital
Vanguard Group
Vanguard Capital Management
Saturn V Capital Management
Kalehua Capital Management
Squadron Capital Management
Millennium Management

View all funds holding Inhibikase Therapeutics